What's New in the Treatment of Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a chronic autoimmune multisystem disease with a variable presentation and manifestations ranging from mild to severe or even life-threatening. There is an ongoing and unmet need for novel, disease-specific, effective and safe treatment modalities. The aim of thi...
Main Authors: | Stamatis Nick Liossis, Chrysanthi Staveri |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.655100/full |
Similar Items
-
Immunophenotyping identifies distinct cellular signatures for systemic lupus erythematosus and lupus nephritis
by: Yi Tong V. Aw, et al.
Published: (2023-03-01) -
Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
by: Marlene Plüß, et al.
Published: (2022-11-01) -
Case report: Isolated tubular basement membrane deposits in a patient with systemic lupus erythematosus - A diagnostic challenge
by: Orlando Vieira Gomes, et al.
Published: (2022-09-01) -
Systemic lupus erythematosus presenting as lupus erythematosus tumidus and lupus nephritis: a case report
by: Meriam Hajji, et al.
Published: (2023-06-01) -
Transcriptomic studies of systemic lupus erythematosus
by: Masahiro Nakano, et al.
Published: (2021-04-01)